Company Long-Term Loans and Borrowings: eliemtx.com (ELYM)
The market trend for Eliem Therapeutics (ELYM) shown on the price chart demonstrates long-term debt levels at 0.00. The business specializes in creating small molecules for the therapy of complex psychiatric disorders, where patent protection will ensure high returns. The company's capital relies on significant cash reserves that fully cover research and development expenses. Its innovative status is confirmed by its authority among biologists and the development of anti-inflammatory agents.
Eliem Therapeutics Inc. (ELYM) - metric breakdowns and financial figures
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- book capitalization information:
- debt level and financial liquidity data:
Debt to Equity Eliem Therapeutics|ELYM - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Eliem Therapeutics, Inc.|ELYM - Company Aggregate Debts|Debts to Book Value Eliem Therapeutics|ELYM - Company Long-Term Debt|Company Current Liabilities Eliem Therapeutics|Intermediate Coverage Ratio eliemtx.com
- earnings and market multiples details:
Summary company analytics:Eliem Therapeutics
Eliem Therapeutics (ELYM) operates in the high-risk biotechnology sector. By analyzing the company's long-term debt chart, an investor assesses obligations with maturities exceeding one year. This metric measures the credit load, determining the balance between financial stability and available capital. For Eliem Therapeutics (ELYM), this is critically important when financing clinical trials for new antibodies. Debt optimization confirms the business's fundamental ability to scale its R&D pipeline.
Competitors of Eliem Therapeutics (ELYM)
Company Long-Term Debts biogen.com BIIB|NBIX - Company Long-Term Debt|Company Long-Term Loans and Borrowings RGC (Regencell Bioscience Ltd)|Axsome Therapeutics Inc (AXSM) - Company Long-Term Debt|Long-Term Debt ACADIA Corp (ACAD)|XENE (Xenon Pharmaceuticals) - Company Long-Term Debts|Long-Term Debt vikingtherapeutics.com VKTX|Company Long-Term Debt Supernus (SUPN)|Company Long-Term Debt CPRX (Catalyst Pharma)|Company Long-Term Debts DNLI (Denali Therapeutics Inc)|Long-Term Debt Volume Harmony Corp (HRMY)|Biohaven Ltd. - Company Long-Term Debts|Long-Term Debt amylyx.com|Trevi Therapeutics, Inc. (TRVI) - Company Long-Term Debt|Company Long-Term Liabilities Praxis Precision Medicines Inc|Company Long-Term Liabilities AVXL|CBLL: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities PRTA (Prothena)|Amount of Long-Term Liabilities ALEC|Company Long-Term Debts ANNX (Annexon)|Company Long-Term Loans and Borrowings OMER|Neurogene Corp - Company Long-Term Debts|Long-Term Debt AC Immune Inc|Voyager Therapeutics (VYGR) - Company Long-Term Debt|neumoratx.com - Company Long-Term Loans and Borrowings|SCLX (Scilex) - Company Long-Term Debts|Company Long-Term Debts Tevogen Bio Holdings Inc.|Company Long-Term Debt Alpha Cognition (ACOG)|CGTX: Long-Term Liabilities|Company Long-Term Debts IKT (Inhibikase Therapeutics)|cassavasciences.com (SAVA) - Long-Term Debt|ASRT: Company Long-Term Liabilities|COYA - Company Long-Term Debts|VTGN (vistagen.com) - Company Long-Term Liabilities|OVID: Amount of Long-Term Liabilities|ABOS (Acumen Pharmaceuticals) - Company Long-Term Debts|cervomed.com (CRVO) - Long-Term Debt Volume|Company Long-Term Debts ATHE|Company Long-Term Liabilities clene.com CLNN|Company Long-Term Debt PepGen PEPG|Long-Term Debt Volume jupiterneurosciences.com (JUNS)|Relmada Therapeutics - Company Long-Term Debts|Long-Term Debt annovisbio.com|gracetx.com (GRCE) - Company Long-Term Debt|AIFF (Firefly Neuroscience, Inc.) - Company Long-Term Debt|Company Long-Term Liabilities KLTO|Long-Term Debt NeuroSense Therapeutics, Ltd. NRSN|Company Long-Term Debt Reviva Pharmaceuticals (RVPH)|Company Long-Term Liabilities metaviatx.com MTVA|Company Long-Term Debt NeurAxis NRXS|HSDT: Company Long-Term Indebtedness|Passage Bio Corp - Company Long-Term Debts|Long-Term Debt Neuphoria Therapeutics Inc.|NERV (Minerva Neurosciences) - Company Long-Term Liabilities|athira.com (ATHA) - Company Long-Term Debts|Company Long-Term Debt Addex Therapeutics Ltd|ALZN: Company Long-Term Loans and Borrowings|Company Long-Term Debt Cyclerion Therapeutics (CYCN)|PTIX - Long-Term Debt|Company Long-Term Debts KTTA (Pasithea Therapeutics Corp.)|Cortigent Inc (CRGT) - Long-Term Debt|ATXI - Company Long-Term Debt|BCLI: Company Long-Term Debt|CARA: Company Long-Term Debts|CHRO - Long-Term Debt Volume|ITCI (Intra-Cellular Therapies Inc.) - Company Long-Term Debts|Long-Term Debt longboardpharma.com LBPH|Company Long-Term Debt Marinus Pharmaceuticals, Inc. (MRNS)|Company Long-Term Liabilities NKGen Biotech Inc NKGN|NeuroBo - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings SAGE|SNPX: Company Long-Term Liabilities|trevena.com - Amount of Long-Term Liabilities|VIGL: Company Long-Term Debts|Anew Medical Inc. - Company Long-Term Loans and Borrowings|CERE (Cerevel) - Company Long-Term Debts